Daniil Georgiyevich Nemenov
Vorstandsvorsitzender bei Aviks Ltd.
Profil
Daniil Georgiyevich Nemenov is currently working as a Medical Director at TheraMAB LLC since 2011, as a Medical Director at Promogen-MAT LLC since 2011, and as the Director General at Aviks Ltd.
since 2014.
Previously, he worked as a Senior VP-Clinical Development & Operations at Ovoca Bio Plc.
He also worked as a Research Associate at the Russian Academy of Sciences from 2008 to 2009, at the Russian State Medical University from 2006 to 2008, and as a Project Manager at Novartis Pharma LLC from 2009 to 2011.
Dr. Nemenov holds a doctorate degree from I.M.
Sechenov First Moscow State Medical University.
Aktive Positionen von Daniil Georgiyevich Nemenov
| Unternehmen | Position | Beginn |
|---|---|---|
TheraMAB LLC
 TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 |
Aviks Ltd.
 Aviks Ltd. Miscellaneous Commercial ServicesCommercial Services Aviks Ltd. engages in the development of treatment for female sexual and reproductive dysfunctions. Its products is called Libicore. The company was founded on July 3, 2012 and is headquartered in Moscow, Russia. | Vorstandsvorsitzender | 25.02.2019 |
Promogen-MAT LLC
 Promogen-MAT LLC Medical/Nursing ServicesHealth Services Promogen-MAT LLC operates as a drug development company. The company was founded in 2010 and is headquartered in Moscow, Russian Federation. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 |
Ehemalige bekannte Positionen von Daniil Georgiyevich Nemenov
| Unternehmen | Position | Ende |
|---|---|---|
| Novartis Pharma LLC | Corporate Officer/Principal | 01.01.2011 |
| Russian Academy of Sciences | Corporate Officer/Principal | 01.01.2009 |
| Russian State Medical University | Corporate Officer/Principal | 01.01.2008 |
| OVOCA BIO PLC | Geschäftsführer | - |
Ausbildung von Daniil Georgiyevich Nemenov
| I.M. Sechenov First Moscow State Medical University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OVOCA BIO PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
TheraMAB LLC
TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Health Technology |
| Novartis Pharma LLC | |
Aviks Ltd.
Aviks Ltd. Miscellaneous Commercial ServicesCommercial Services Aviks Ltd. engages in the development of treatment for female sexual and reproductive dysfunctions. Its products is called Libicore. The company was founded on July 3, 2012 and is headquartered in Moscow, Russia. | Commercial Services |
Promogen-MAT LLC
Promogen-MAT LLC Medical/Nursing ServicesHealth Services Promogen-MAT LLC operates as a drug development company. The company was founded in 2010 and is headquartered in Moscow, Russian Federation. | Health Services |
